Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.7 (
acetylcholinesterase
)
28,390
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Enzyme activities associated with the neurotransmitter pathways in nerve growth factor-treated, 139A scrapie strain-infected PC12 cells were examined. Since these cells show no morphological alterations during the time of agent replication, any scrapie-induced effects would have to be associated with non-vital cellular functions. When compared to controls, infection with the 139A scrapie strain resulted in decreased activity of the cholinergic pathway-related enzymes, choline acetyltransferase and
acetylcholinesterase
. However, the adrenergic pathway was unaffected by scrapie infection as evidenced by unaltered tyrosine hydroxylase activity, the putative rate-limiting enzyme in the synthesis of catecholamines. The effects of the 139A scrapie strain on the cholinergic system appeared to be dose-dependent and were first detected prior to the detection of scrapie agent replication in these cells. Furthermore, the altered enzymic activities observed were not the result of contaminating material in the scrapie brain homogenate because similar results were obtained when partially purified scrapie preparations were used as the inoculum. These scrapie agent-induced alterations in specific neuronal properties suggest a mechanism for the clinical manifestations observed in scrapie and perhaps other related central nervous system disorders.
J
Gen
Virol 1991 Jun
PMID:Alterations in neurotransmitter-related enzyme activity in scrapie-infected PC12 cells. 167 47
We have investigated neurotransmitter-related markers of the cerebrospinal fluid (CSF) in a carefully screened series of normally aging subjects in standardized conditions in order to find out the influence of age and other confounding factors on CSF measures. The levels of 3-methoxy-4-hydroxyglycol (MHPG) and the activity of
acetylcholinesterase
(
AChE
) also increased with age, while homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5 HIAA) and immunoreactivities of somatostatin (SLI), beta-endorphin (BLI) and adrenocorticotropic hormone (ACTH) were unrelated to age. The gender of subjects had no significant effect on the levels of neurotransmitter markers, while seasonal changes, as well as height and weight of the subjects seemed to cause some variations in the levels of HVA, dopamine-beta-hydroxylase (DBH) and ACTH. The study underscores the importance of standardized conditions and matched patient groups in the CSF studies.
J Neural Transm
Gen
Sect 1991
PMID:Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors. 167 57
1. The inhibition of
cholinesterase
and carboxylesterase activities in the diisopropyl fluorophosphate (DFP) intoxication, and the inducibility of organophosphate (OP) detoxicating enzymes was studied in rats. 2. In phenobarbital (PB)-, but not in beta-naphthoflavone (NF)-pretreated rats, the activities of DFP-inhibited cholinesterases were 70-120% higher than in non-pretreated rats. Also the inhibition of the microsomal and cytosolic carboxylesterase activity in liver was efficiently antagonized by BP, but not by NF. 3. In vitro the microsomes from PB-treated rats detoxicated DFP probably by O-dealkylation, since no fluoride was released from DFP. Glutathione S-transferase did not detoxicate DFP. 4. 7-Pentoxyresorufin O-dealkylase, a specific enzyme of cytochrome P450IIB subfamily, was induced by PB, flumecinol, isosafrole and NF by 167- 61-, 26- and 1.6-fold, respectively. 7-Ethoxyresorufin O-deethylase, a marker enzyme of cytochrome P450IA subfamily, was induced by those agents 5-, 4-, 31- and 94-fold, given in the same order. Glutathione S-transferase, paraoxonase and DFPase activities were increased 0-72% by the tested inducers. 5. The results suggest that the cytochrome P450IIB subfamily, inducible by PB, participates in DFP detoxication by O-dealkylation. Its induction probably causes the protection against the
cholinesterase
inhibition by OPs.
Gen
Pharmacol 1990
PMID:Inhibition of cholinesterases by DRP and induction of organophosphate-detoxicating enzymes in rats. 216 59
To assess central nervous system cholinergic neuroendocrine regulation in Alzheimer's disease (AD), we measured plasma arginine vasopressin, beta-endorphin, and epinephrine responses to a cholinergic challenge elicited by intravenous administration of the
acetylcholinesterase
inhibitor physostigmine (0.0125 mg/kg) in male patients with AD (n = 12) and compared their responses with those of age-matched normal control subjects (n = 12). Physostigmine promptly increased plasma arginine vasopressin (tenfold), beta-endorphin (twofold to threefold) and epinephrine (threefold) levels in elderly control subjects. In contrast, patients with AD showed attenuated responses to physostigmine. When controls and patients with AD who experienced nausea (n = 2 and n = 6, respectively) were excluded, the arginine vasopressin, beta-endorphin, and epinephrine responses of patients with AD were significantly less than those of control subjects. These data suggest that the central nervous system cholinergic deterioration of AD results in decreased responsiveness of neuroendocrine systems that are regulated by central cholinergic mechanisms.
Arch
Gen
Psychiatry 1989 Jun
PMID:Neuroendocrine responses to physostigmine in Alzheimer's disease. 252 15
1. The effect of cold environment on the acute toxicity of organophosphates (OP), without and with atropine-oxime treatment, was studied in rats and mice by exposing them to +5 and -5 degrees C temperature. The tested OPs and oximes (given intraperitoneally) were diisopropylfluorophosphate (DFP), isopropyl methylphosphonofluoridate (sarin) and dichlorovinyl phosphate (DDVP), pralidoxime (PAM) and obidoxime. 2. An exposure to low environmental temperature decreased the effectiveness of atropine-oxime therapy in OP poisoned rats and mice, evaluated by means of acute LD50 values. 3. The lowering of environmental temperature did not influence the ability of PAM to reactivate tissue
cholinesterase
in rats intoxicated by 0.5 x LD50 doses of DFP. 4. The acute toxicity of atropine and oximes was not affected by cold environment in rats, but in mice it was increased by 1.1-2.1 times. 5. The decrease in the effectiveness of atropine-oxime therapy at cold environment may be explained by the observation that the cold temperature sensitizes the animals to the inhibition of brain
acetylcholinesterase
by OP.
Gen
Pharmacol 1989
PMID:Cold exposure decreases the effectiveness of atropine-oxime treatment in organophosphate intoxication in rats and mice. 268 80
1. The responsiveness of dystrophic avian muscle to acetylcholine may be altered due to reported elevated
acetylcholinesterase
activity. 2. To test this hypothesis, the responsiveness of normal and dystrophic muscle in vivo to intra-arterial injection of acetylcholine, carbamylcholine and d-tubocurarine was compared. 3. Results showed that dystrophic muscle was less responsive to acetylcholine, more responsive d-tubocurarine and equally responsive to carbamylcholine when compared to normal suggesting enhanced acetylcholine hydrolysis occurs in vivo in dystrophic avian muscle.
Gen
Pharmacol 1988
PMID:Responsiveness of normal and dystrophic avian muscle to acetylcholine, carbamylcholine and d-tubocurarine. 321 81
1. Cholinesterase activities in blood and tissues of control and exercising rats with and without organophosphate (OP) exposure were studied. 2. Physical exercise increased total
cholinesterase
and butyrylcholinesterase activities in rats without OP exposure in blood and diaphragm. In brain physical exercise had no effect on
acetylcholinesterase
activity. 3. Physical exercise diminished
cholinesterase
inhibition in blood and tissues after OP exposure.
Gen
Pharmacol 1988
PMID:Physical exercise affects cholinesterases and organophosphate response. 322 22
1. Rabbit serum was shown to contain two cholinesterases which hydrolysed acetylthiocholine and butyrylthiocholine and one
cholinesterase
which hydrolysed only butyrylthiocholine. 2. The three enzymes were identified by the kinetics of heat inactivation and kinetics of phosphorylation by the organophosphate VX. 3. Using selective inhibitors (iso-OMPA, eserine, BNPP and BW-284C51) it was shown that the hydrolysis of acetylthiocholine and butyrylthiocholine in untreated native serum had properties of
acetylcholinesterase
(
EC 3.1.1.7
), butyrylcholinesterase (EC 3.1.1.8) and also some properties of carboxylesterase (EC 3.1.1.1). 4. Separation of proteins (on PAA-gels) in untreated native serum gave four bands with acetylthiocholine and three with butyrylthiocholine. 5. The two cholinesterases hydrolysing both substrates corresponded to the slow moving bands on the gel. 6. The fastest moving band hydrolysing only butyrylthiocholine could be attributed to the
cholinesterase
least sensitive to VX.
Gen
Pharmacol 1988
PMID:Cholinesterases in rabbit serum. 322 26
A new separation method using a hand-driven discoidal micro-centrifuge was developed. It is suitable for separating red cells from plasma in field conditions. The amounts of plasma produced are sufficient to be used for the dip-stick estimation of pseudocholinesterase activity. The strip estimations of plasma pseudochoninesterase activity correlated well with the spectrophotometric method of plasma
cholinesterase
. The test paper methods seem to be reliable under field conditions in acute organophosphate poisonings. To verify the results of the paper strip methods the blood method absorbed on paper can be used. This method is applicable for the measuring of blood
cholinesterase
activities and thus monitoring humans exposed to organophosphates under field conditions.
Gen
Pharmacol 1987
PMID:A simple method for the measurement of blood cholinesterase activities under field conditions. 356 45
The innervation of Rana ridibunda stomach has been studied by the following methods: demonstration of
cholinesterase
activity; FIF method for catecholamines; immunohistochemistry for VIP; SP and SOM and conventional electron microscopy. The cholinergic innervation is important in the stomach wall where in addition to the intrinsic plexuses there is an extrinsic contribution coming with the vagus nerve. The density of the fibres decreases towards the pyloric sphincter. The adrenergic innervation seems to be almost entirely of extrinsic origin. Fine networks have been localized at the myenteric and submucosal plexuses. The fibres density increases at the pylorus. At the myenteric plexus, apart from the cholinergic neurons, we have found VIP and SOM like cells. The VIP like plexus is very well developed. A SOM like plexus is also present but with scarce fibres in comparison with the VIPergic one. The submucosal plexus is exclusively made by nervous fibres of the types described for the myenteric one. We have got positive immunoreactivity for SP only on the fibres. They are scarce in the stomach wall, only at the pyloric region their density increases. We describe the ultrastructural morphological characteristics of the enteric neurons as well as the fine inter-relationships between the nervous elements and the functional components of the stomach wall.
Gen
Pharmacol 1986
PMID:The enteric nervous system of Rana ridibunda stomach. 378 Dec 9
<< Previous
1
2
3
4
5
6
7
8
9
Next >>